<\/p>\n
India\u2019s pharmaceutical industry will be able to produce Covid-19 vaccines not just for the country but also for the entire world, according to Microsoft co-founder and philanthropist Bill Gates.<\/p>\n
A lot of \u201cvery important things have been done\u201d in India and its pharma industry is doing work \u201cto help make the coronavirus vaccine building on other great capacities that they have used for other diseases\u201d, said the Co-Chair and Trustee of Bill and Melinda Gates Foundation.<\/p>\n
Speaking in a documentary — Covid-19: India\u2019s War Against The Virus — to be premiered on Discovery Plus this (Thursday) evening, Gates said India also faces a huge challenge due to the health crisis because of its gigantic size and urban centres with a lot of population density.<\/p>\n
Click here for the complete coverage of the Covid-19 pandemic<\/a><\/b><\/p>\n Commenting on the strength of India\u2019s pharma industry, he said, \u201cIndia has a lot of capacity there — with the drug and vaccine companies that are huge suppliers to the entire world. You know, more vaccines are made in India than anywhere– starting with Serum Institute, that\u2019s the largest.\u201d He further said, \u201cBut (there are) also Bio E, Bharat (Biotech), many others. They are doing work to help make the coronavirus vaccine, building on other great capacities that they have used for other diseases.\u201d <\/p>\n Also Read: China OKs human test for Covid-19 vaccine candidate based on BioNTech\u2019s technology:Report<\/a><\/b><\/p>\n Stating that India joined Coalition for Epidemic Preparedness Innovations (CEPI), which is a group working on a global basis to build vaccines platforms, Gates said, \u201cI am excited that the pharmaceutical industry there will be able to produce not just for India but also for the entire world. (This is) What we need to reduce the deaths and make sure we are immune, which is how we end the epidemic.\u201d Gates said Bill and Melinda Gates Foundation is also a \u201cpartner with the government, particularly with the department of biotechnology, the Indian Council of Medical Research (ICMR) and the office of the principal scientific advisor provide advice and help about getting these tools going\u201d.<\/p>\n